BACKGROUND: There is no reliable marker available for early detection, diagnostic confirmation, or disease prognosis available of prostate cancer (PCa). We aimed to evaluate the function of Cullin-1 and unravel its underlying molecular mechanism to develop novel treatment options equivalent to PCa. METHOD: We used immunohistochemistry to analyze the correlation between Cullin-1 expression and clinicopathologic variables and patient survival. The Cullin-1 level was tested in PCa cells. The role of regulation of Cullin-1 in PCa was applied in vitro and vivo. In addition, we further investigated the signaling pathway of Cullin-1 in prostate cancer cell proliferation. RESULT: We first discovered that Cullin-1 expression was upregulated in human PCa tissues and inversely related with PCa differentiation. We then found that high expression of Cullin-1 protein suggested a poor prognosis in PCa patients. Also, Cullin-1 promotes PCa cell proliferation in vitro and tumor growth in vivo. We then found that the mechanism of Cullin-1 regulation on cell-cycle progression is due to increased expression of p21 and p27, and decreased expression of cyclin D1 and cyclin E after Cullin-1 knockdown. CONCLUSION: Cullin-1 exerts multiple biological effects in the PCa cell line. Through promoting proliferation and by countering cisplatin-induced apoptosis, Cullin-1 has been deeply implicated in the pathogenesis and development of PCa.
BACKGROUND: There is no reliable marker available for early detection, diagnostic confirmation, or disease prognosis available of prostate cancer (PCa). We aimed to evaluate the function of Cullin-1 and unravel its underlying molecular mechanism to develop novel treatment options equivalent to PCa. METHOD: We used immunohistochemistry to analyze the correlation between Cullin-1 expression and clinicopathologic variables and patient survival. The Cullin-1 level was tested in PCa cells. The role of regulation of Cullin-1 in PCa was applied in vitro and vivo. In addition, we further investigated the signaling pathway of Cullin-1 in prostate cancer cell proliferation. RESULT: We first discovered that Cullin-1 expression was upregulated in human PCa tissues and inversely related with PCa differentiation. We then found that high expression of Cullin-1 protein suggested a poor prognosis in PCa patients. Also, Cullin-1 promotes PCa cell proliferation in vitro and tumor growth in vivo. We then found that the mechanism of Cullin-1 regulation on cell-cycle progression is due to increased expression of p21 and p27, and decreased expression of cyclin D1 and cyclin E after Cullin-1 knockdown. CONCLUSION:Cullin-1 exerts multiple biological effects in the PCa cell line. Through promoting proliferation and by countering cisplatin-induced apoptosis, Cullin-1 has been deeply implicated in the pathogenesis and development of PCa.
Entities:
Keywords:
Cullin-1; diagnosis; proliferation; prostate cancer
Authors: Daming Gao; Lixin Wan; Hiroyuki Inuzuka; Anders H Berg; Alan Tseng; Bo Zhai; Shavali Shaik; Eric Bennett; Adriana E Tron; Jessica A Gasser; Alan Lau; Steven P Gygi; J Wade Harper; James A DeCaprio; Alex Toker; Wenyi Wei Journal: Mol Cell Date: 2010-09-10 Impact factor: 17.970
Authors: Carlton R Cooper; Christopher H Chay; James D Gendernalik; Hyung-Lae Lee; Jasmine Bhatia; Russell S Taichman; Laurie K McCauley; Evan T Keller; Kenneth J Pienta Journal: Cancer Date: 2003-02-01 Impact factor: 6.860
Authors: Harm Westdorp; Annette E Sköld; Berit A Snijer; Sebastian Franik; Sasja F Mulder; Pierre P Major; Ronan Foley; Winald R Gerritsen; I Jolanda M de Vries Journal: Front Immunol Date: 2014-05-06 Impact factor: 7.561
Authors: A K M Nawshad Hossian; Md Sanaullah Sajib; Paul E Tullar; Constantinos M Mikelis; George Mattheolabakis Journal: Sci Rep Date: 2018-07-12 Impact factor: 4.379